Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

Publisher： Karger

E-ISSN： 1421-9832|225|4|312-319

ISSN： 1018-8665

Source： Dermatology, Vol.225, Iss.4, 2012-12, pp. : 312-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 230, Iss. 1, 2015-01 ,pp. : 46-54

Karger

Access to resources Recommend Favorite

Prospective Randomized Long-Term Study on the Efficacy and Safety of UV-Free Blue Light for Treating Mild Psoriasis Vulgaris

By  

Dermatology, Vol. 231, Iss. 1, 2015-06 ,pp. : 24-34

Karger

Access to resources Recommend Favorite

A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis

By  

Dermatology, Vol. 217, Iss. 4, 2008-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials

By  

Dermatology, Vol. 220, Iss. 1, 2009-11 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia

By  

Case Reports in Dermatology, Vol. 3, Iss. 1, 2011-03 ,pp. : 60-63

Karger

Access to resources Recommend Favorite